Vanta Bioscience Limited reported unaudited earnings results for the half year ended September 30, 2018. For the half year, the company reported revenue from operations of INR 60.222 million compared to INR 4.935 million for the same period a year ago. Profit before exceptional and extraordinary items was INR 4.583 million compared to INR 0.629 million for the same period a year ago. Profit before tax was INR 4.583 million compared to INR 0.629 million for the same period a year ago. Profit for the period was INR 2.930 million compared to loss of INR 0.236 million for the same period a year ago. Basic earnings per share was INR 0.51.